BackAtara Biotherapeutics Overview

Atara Biotherapeutics Current Assets

Atara Biotherapeutics's current assets is $14M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$13.53M
↓ 45.38% YoYΔ $-11.24M vs prior year quarter

Peer trimmed avg / median

Loading

Atara Biotherapeutics Current Assets History

Loading

Atara Biotherapeutics vs. peers: Current Assets Comparison

Loading

Atara Biotherapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Atara Biotherapeutics (ATRA) FAQ

As of the most recent data (June 2026), ATRA shows a current assets of $14M. That compares with $25M in the prior-year period — down 45.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATRA's current assets is now $14M (was $25M) — a 45.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Atara Biotherapeutics is outperforming or lagging.

Tracking ATRA's current assets over time shows whether Atara Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $25M in the prior-year period — down 45.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Atara Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $14M) with ownership activity and broader fundamentals.

Atara Biotherapeutics's current assets is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.